Lucas Opazo-Ríos

11PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsMedical biochemistry - lipidsNutrigenomics and personalised nutritionPoverty, inclusivity and wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 14, 2026
SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob.

Marcelo Aguilar-Cartes, Lucas Opazo-Ríos, Alejandra Droguett

|Jun 26, 2025
The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights.

Antonio Tejera-Muñoz, Vanessa Marchant, Lucía Tejedor-Santamaría

|Mar 13, 2024
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

Manuel Soto-Catalán, Lucas Opazo-Ríos, Hernán Quiceno

|Apr 12, 2022
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice.

Lucas Opazo-Ríos, Manuel Soto-Catalán, Iolanda Lázaro

|Dec 24, 2021
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.

Luna Jiménez-Castilla, Gema Marín-Royo, Macarena Orejudo

|Jan 20, 2021
Toll-Like Receptors in Acute Kidney Injury.

Cristina Vázquez-Carballo, Melania Guerrero-Hue, Cristina García-Caballero

Pageof 2

Frequent Collaborators

7 joint publications

Carmen Gómez-Guerrero

7 joint publications

Juan Antonio Moreno

5 joint publications

Sebastián Mas-Fontao

1 joint publications

Raúl R Rodrigues-Díez